These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmaceutical Portfolio & Product Life Cycle Management--SMi's fourth annual conference. 29-30 June 2009, London, UK. Beecher N IDrugs; 2009 Sep; 12(9):558-60. PubMed ID: 19697274 [No Abstract] [Full Text] [Related]
4. Building predictive ADMET models for early decisions in drug discovery. Penzotti JE; Landrum GA; Putta S Curr Opin Drug Discov Devel; 2004 Jan; 7(1):49-61. PubMed ID: 14982148 [TBL] [Abstract][Full Text] [Related]
5. Role of pharmacokinetics and metabolism in drug discovery and development. Lin JH; Lu AY Pharmacol Rev; 1997 Dec; 49(4):403-49. PubMed ID: 9443165 [No Abstract] [Full Text] [Related]
7. Elementary pharmacokinetics in clinical practice 2: Basic concepts of drug pharmacokinetics. Paxton JW N Z Med J; 1981 Nov; 94(695):342-5. PubMed ID: 6950264 [No Abstract] [Full Text] [Related]
8. Prediction of ADMET Properties. Norinder U; Bergström CA ChemMedChem; 2006 Sep; 1(9):920-37. PubMed ID: 16952133 [TBL] [Abstract][Full Text] [Related]
9. Advances and Progress in Drug Design - SMi's ninth annual meeting. Welchman R IDrugs; 2010 Apr; 13(4):239-42. PubMed ID: 20373252 [TBL] [Abstract][Full Text] [Related]
10. [General concepts of pharmacokinetics]. Valli M; Bruguerolle B; Bouyard P Ann Anesthesiol Fr; 1981; 22(2):101-9. PubMed ID: 6115597 [No Abstract] [Full Text] [Related]
11. Adaptive designs in clinical drug development--SMi's third annual conference. 4-5 February 2009, London, UK. Padhiar M IDrugs; 2009 Apr; 12(4):230-2. PubMed ID: 19350466 [No Abstract] [Full Text] [Related]
12. Using ontogeny information to build predictive models for drug elimination. Alcorn J; McNamara PJ Drug Discov Today; 2008 Jun; 13(11-12):507-12. PubMed ID: 18549977 [TBL] [Abstract][Full Text] [Related]
13. Drug Design--SMi's Third Annual Conference. 23-24 February 2004, London UK. Austin S IDrugs; 2004 Apr; 7(4):331-3. PubMed ID: 15057638 [No Abstract] [Full Text] [Related]
14. Superbugs and superdrugs--SMi's 8th annual conference. A focus on antimicrobials. 24-25 April 2006, London, UK. Chan D IDrugs; 2006 Jul; 9(7):471-3. PubMed ID: 16821157 [No Abstract] [Full Text] [Related]
15. Generation of a set of simple, interpretable ADMET rules of thumb. Gleeson MP J Med Chem; 2008 Feb; 51(4):817-34. PubMed ID: 18232648 [TBL] [Abstract][Full Text] [Related]
17. Pharmacometrics as a discipline is entering the "industrialization" phase: standards, automation, knowledge sharing, and training are critical for future success. Romero K; Corrigan B; Tornoe CW; Gobburu JV; Danhof M; Gillespie WR; Gastonguay MR; Meibohm B; Derendorf H J Clin Pharmacol; 2010 Sep; 50(9 Suppl):9S-19S. PubMed ID: 20881213 [No Abstract] [Full Text] [Related]
18. Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches. Khan MT Curr Drug Metab; 2010 May; 11(4):285-95. PubMed ID: 20450477 [TBL] [Abstract][Full Text] [Related]
19. [The mechanisms of the realization of stereoselectivity in pharmacokinetics]. Rumiantsev DO; Piotrovskiĭ VK Eksp Klin Farmakol; 1994; 57(3):65-9. PubMed ID: 8049624 [No Abstract] [Full Text] [Related]